Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

An Open-Label Long-Term Safety Study of Serlopitant for the Treatment of Pruritus

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT03540160
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:09.860221+00:00
Published At
2020-11-30T00:00:00+00:00
Record Updated At
2021-05-20
Results Posted At
2020-11-30
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Pruritus", "Prurigo Nodularis", "Atopic Dermatitis", "Psoriasis"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-05-20"
protocolSection.identificationModule.nctId
"NCT03540160"
protocolSection.identificationModule.officialTitle
"An Open-Label Long-Term Safety Study of Serlopitant for the Treatment of Pruritus"
protocolSection.statusModule.overallStatus
"TERMINATED"
protocolSection.designModule.phases
["PHASE3"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-11-30"

Study condition terms

  • Pruritus (protocolSection.conditionsModule.conditions)
  • Prurigo Nodularis (protocolSection.conditionsModule.conditions)
  • Atopic Dermatitis (protocolSection.conditionsModule.conditions)
  • Psoriasis (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.